Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271960 · ClinicalTrials.gov registry record · Phase 3
Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,047
- Enrollment target
NCT00271960: Completed Phase 3 study, sponsored by Yale University.
NCT00271960 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 1,047 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (36% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00271960, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,047 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of two group prenatal care programs as compared to individual prenatal care in reducing the risk for HIV, STDs and adverse perinatal outcomes in young women during and after pregnancy.
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL CenteringPregnancy
- BEHAVIORAL CenteringPregnancyPlus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,047 participants |
| Start Date | 2001-04 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
What the finished NCT00271960 record still lists
NCT00271960 is an interventional study that assigns participants to a tested intervention. Its 1,047 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (36% higher).
The record links to 0 conditions, and to 3 interventions - of which Usual care is the first listed.
NCT00271960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00271960 about?
NCT00271960 is a clinical study titled "Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women". This study will determine the effectiveness of two group prenatal care programs as compared to individual prenatal care in reducing the risk for HIV, STDs and adverse perinatal outcomes in young women during and after pregnancy.
What is the current status of trial NCT00271960?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,047 participants. The study started on 2001-04. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00271960?
The interventions under investigation include: Usual care (BEHAVIORAL), CenteringPregnancy (BEHAVIORAL), CenteringPregnancyPlus (BEHAVIORAL).
Who is sponsoring clinical trial NCT00271960?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00271960's enrollment target sits among peer trials
1,047 283rd of 2000 higher than 1,718 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06717347 · 1,046 participants · Phase 3
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia